Back
Akero Therapeutics Vs. Dave Industry Stock Comparison
Sell
28
AKRO
Akero Therapeutics
Last Price:
$28.90
Seasonality Move:
-9.11%
Buy
90
DAVE
Dave
Last Price:
$100.46
Seasonality Move:
103.78%
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $28.56. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.56Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.62 | Sell |
Relative Strength Index (14 RSI): | 42.92 | Sell |
Chaikin Money Flow: | 107245 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.15 - 31.69) | Sell |
Bollinger Bands (100): | (26.14 - 31.32) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.7 | Buy |
Relative Strength Index (14 RSI): | 60.3 | Buy |
Chaikin Money Flow: | 336947 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (83.31 - 95.25) | Buy |
Bollinger Bands (100): | (30.87 - 76.61) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.02 | Sell |
20-day SMA: | 30.16 | Sell |
50-day SMA: | 30.77 | Sell |
200-day SMA: | 25.89 | Buy |
8-day EMA: | 29.06 | Sell |
20-day EMA: | 29.8 | Sell |
50-day EMA: | 29.96 | Sell |
200-day EMA: | 27.84 | Buy |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 93.41 | Buy |
20-day SMA: | 90.93 | Buy |
50-day SMA: | 69.71 | Buy |
200-day SMA: | 46.28 | Buy |
8-day EMA: | 91.77 | Buy |
20-day EMA: | 88.14 | Buy |
50-day EMA: | 74.64 | Buy |
200-day EMA: | 48.61 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.78 per share.
Akero Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |